Merigest and neoplasm malignant Patient Reports February 09, 2010

Merigest Side Effects Report #5711709-1
Merigest side effect was reported by a Consumer or non-health professional from on Apr 14, 2008. Female patient, 58 years of age, was diagnosed with menopausal symptoms and was treated with Merigest. After drug was administered, patient experienced the following side effects: neoplasm malignant. Merigest dosage: 2/0, 7 MG. Patient died.